Matches in Wikidata for { <http://www.wikidata.org/entity/Q63583346> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q63583346 description "clinical trial" @default.
- Q63583346 description "ensayu clínicu" @default.
- Q63583346 description "klinisch onderzoek" @default.
- Q63583346 description "клінічне випробування" @default.
- Q63583346 name "A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer" @default.
- Q63583346 type Item @default.
- Q63583346 label "A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer" @default.
- Q63583346 prefLabel "A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer" @default.
- Q63583346 P1132 Q63583346-DF8B2D9D-C61D-4F99-8FFE-EC034CE73B52 @default.
- Q63583346 P1476 Q63583346-ED3DE1F3-4CC5-4ED9-BE15-A0A5B764EEBD @default.
- Q63583346 P17 Q63583346-211CBCE6-FF78-4CFC-9A16-24A6D8C5A884 @default.
- Q63583346 P1813 Q63583346-800DBE73-88D7-407D-AF62-219C4AE471C2 @default.
- Q63583346 P2899 Q63583346-E0753193-7710-45C1-A83B-73C7231E7F1D @default.
- Q63583346 P3098 Q63583346-73B3A605-4C24-49FE-BDE1-2D0FB268E10A @default.
- Q63583346 P31 Q63583346-7052A335-A9E3-4950-B34C-CC0D189CE398 @default.
- Q63583346 P4844 Q63583346-4A48FF8E-36BA-4527-BF3F-C30B6CA0E25B @default.
- Q63583346 P4844 Q63583346-4EC87920-3970-47D2-A6C3-CE10B5193ED6 @default.
- Q63583346 P4844 Q63583346-E5ADAA33-11CB-4331-9350-9CDACCD315DC @default.
- Q63583346 P4844 Q63583346-F05B1CEB-B20B-40C8-8FE0-DE6D633E839E @default.
- Q63583346 P580 Q63583346-FD45D3B0-9A6F-457C-8729-CF344ECDF408 @default.
- Q63583346 P582 Q63583346-BCBFC64F-2181-4022-82CE-94A23A9A70E0 @default.
- Q63583346 P6099 Q63583346-58546D83-1392-4CE6-BA55-AE3C751CEC97 @default.
- Q63583346 P8363 Q63583346-E6A2D6D7-47C8-4FCE-BF6D-03F492BD6AB2 @default.
- Q63583346 P921 Q63583346-10FDA9DD-7CD1-4566-8C72-27FB69D46F2F @default.
- Q63583346 P1132 "+0" @default.
- Q63583346 P1476 "Phase III Study to Compare Trastuzumab-biosimilar (Kanjinti®) Plus Pertuzumab Plus Vinorelbine With Trastuzumab-biosimilar (Kanjinti®) Plus Pertuzumab Plus Docetaxel as First-line Treatment for HER2-positive Advanced Breast Cancer" @default.
- Q63583346 P17 Q183 @default.
- Q63583346 P1813 "ATTILA" @default.
- Q63583346 P2899 "+18" @default.
- Q63583346 P3098 "NCT03811418" @default.
- Q63583346 P31 Q30612 @default.
- Q63583346 P4844 Q1998021 @default.
- Q63583346 P4844 Q412616 @default.
- Q63583346 P4844 Q420436 @default.
- Q63583346 P4844 Q420532 @default.
- Q63583346 P580 "2019-03-01T00:00:00Z" @default.
- Q63583346 P582 "2023-12-31T00:00:00Z" @default.
- Q63583346 P6099 Q42824827 @default.
- Q63583346 P8363 Q78089383 @default.
- Q63583346 P921 Q13100823 @default.